2023-08-15 16:37:13 ET
More on AngioDynamics
- AngioDynamics, Inc. ( ANGO ) Q4 2023 Earnings Call Transcript
- AngioDynamics, Inc. 2023 Q4 - Results - Earnings Call Presentation
- A Win-Win Scenario From The AngioDynamics And Merit Medical Deal
- AngioDynamics: AngioVac, Profit Headwinds Not Attractive
- AngioDynamics completes $100M sale of dialysis, BioSentry products
- DexCom raised, AngioDynamics cut as RayJay reviews post-COVID MedTech
- AngioDynamics Non-GAAP EPS of -$0.03 misses by $0.02, revenue of $80.7M misses by $2.49M
- AngioDynamics drops as jury sides with Becton Dickinson in patent dispute
- Seeking Alpha’s Quant Rating on AngioDynamics
- Earnings data for AngioDynamics
For further details see:
AngioDynamics gets FDA breakthrough status for AngioVac indication